Appetite Suppression Sparks Spending Drops (Image Credits: Pixabay)
Weight loss medications such as Ozempic and Wegovy have driven consumers toward more deliberate eating patterns, forcing the food industry to confront profound changes.
Appetite Suppression Sparks Spending Drops
Households starting GLP-1 treatments saw grocery spending fall by an average of 5.3 percent within six months.[1][2] Higher-income families experienced even steeper declines, exceeding 8 percent. These reductions persisted for at least a year among ongoing users, though they tapered over time. Restaurant visits, particularly to fast-food outlets, dropped by about 8 percent as well.
Researchers observed that overall food purchases simply decreased, with few categories bucking the trend. After users discontinued the drugs, spending patterns reverted to pre-treatment levels, including a slight uptick in less healthy items like candy.[1] A KPMG analysis reported a 21 percent drop in caloric intake and a 31 percent decline in monthly grocery expenditures among users.[3]
Processed Foods Bear the Brunt
Current and former GLP-1 users reported cutting back sharply on ultra-processed and calorie-dense items. About 70 percent more respondents consumed less processed food compared to those eating more of it. Soda and refined grains followed, with roughly 50 percent more users reducing intake.[4]
Savory snacks like chips fell by 10 to 11 percent, alongside sweets, baked goods, and meats. Beef and pork consumption also declined notably. Non-users showed no such widespread reductions. Even so, users retained a desire for these foods despite eating less.
- Processed foods: 70% net reduction in reported consumption
- Soda: 50% net reduction
- Refined grains: 50% net reduction
- Beef: 50% net reduction
- Starchy vegetables, alcohol, fruit juice: Notable decreases
Protein and Produce Gain Traction
While overall volumes shrank, demand grew modestly for nutrient-dense options. Yogurt sales surged nearly threefold in GLP-1 households, especially low-sugar Greek varieties.[5] Fresh fruits, nutrition bars, and meat snacks saw small upticks. Fruits, leafy greens, and water emerged as the few categories with net increases.
Industry leaders noted this pivot. General Mills CEO Jeff Harmening observed that the drugs nudge consumers toward “smaller portions and more nutrient-dense protein and fiber-forward foods.”[2] About one in eight U.S. adults now uses these medications, with over half eligible.
Companies Pivot to Meet New Demands
Food giants responded swiftly with tailored innovations. Nestlé introduced Vital Pursuit, its first major U.S. brand in decades, aimed at GLP-1 users. Conagra Brands applied “GLP-1 friendly” labels to Healthy Choice meals and launched protein-packed items like Slim Jim meat sticks.
Danone expanded Oikos with muscle-building drinks, while General Mills offered smaller packs and protein-enriched cereals. These moves target maintenance phases post-weight loss. Conagra’s Bob Nolan emphasized products for users “once you’ve achieved your target weight.”[2]
| Category | Spending Change (GLP-1 Users) |
|---|---|
| Grocery Overall | -5.3% to -6% |
| Snacks/Sweets | -10% |
| Yogurt/Protein | + Modest Increase |
| Restaurants | -8% |
Key Takeaways
- GLP-1 users cut processed and sugary items most sharply, boosting healthier alternatives.
- Grocery spending drops persist but reverse upon discontinuation.
- Food companies launch protein-focused lines to capture the growing user base.
Early forecasts of GLP-1s disrupting food demand have proven accurate, with households using the drugs poised to represent over a third of sector sales in coming years.[2] The industry now braces for sustained shifts as cheaper, oral versions emerge. What changes have you noticed in your shopping habits? Share in the comments.
